Patent Assignment
Reel/Frame 072172/0272
Assignment of Assignor's Interest
Recorded: 2025-09-05
Pages: 8
Assignors
REN, SHUNLIN
Executed: 2019-03-27
XU, LEYUAN
Executed: 2019-03-28
NING, YANXIA
Executed: 2019-04-09
KIM, JIN KOUNG
Executed: 2019-03-28
LIN, WEIQI
Executed: 2019-02-05
KIM, MEE JEAN
Executed: 2019-02-05
MIKSZTAL, ANDREW R.
Executed: 2019-02-05
WU, HONGWEI
Executed: 2019-02-15
LEE, MIN L.
Executed: 2019-02-26
TAMRAZ, WILMA
Executed: 2019-02-26
Assignees
VIRGINIA COMMONWEALTH UNIVERSITY
800 EAST LEIGH STREET, SUITE 3000, RICHMOND, VIRGINIA, 23219
DURECT CORPORATION
10240 BUBB ROAD, CUPERTINO, CALIFORNIA, 95014 -416
Covered Property
(1)
Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof And at Least One Cyclic Oligosaccharide
Application:
19/011,381 →
Publication:
US 2025/0249021
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 5, 2025
From: VIRGINIA COMMONWEALTH UNIVERSITY
To: VIRGINIA COMMONWEALTH UNIVERSITY; THE UNITED STATESGOVERNMENTAS REPRESENTEDBY THEDEPARTMENTOFVETERANS AFFAIRS
Reel/Frame 072172/0570 →
Merger
Feb 19, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073837/0231 →
Merger
Feb 25, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073889/0196 →
Security Interest
Mar 30, 2026
From: BAUSCH HEALTH IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 074223/0753 →
Security Interest
Mar 30, 2026
From: MEDICIS PHARMACEUTICAL CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 074227/0509 →